Evidence map›Paper›PMID 31143774›Full record

ArticleBioMed research international2019

The Efficacy and Safety of Transcatheter Arterial Embolization to Treat Renal Hemorrhage after Percutaneous Nephrolithotomy.

Nan Du, Jing-Qin Ma, Jian-Jun Luo, Qing-Xin Liu, Zi-Han Zhang, Min-Jie Yang, Tian-Zhu Yu, Yun Tao, Rong Liu, Wen Zhang and 1 more

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Value of Angioembolization in the Treatment of Iatrogenic Renal Vascular Injury Assisted by 3-Dimensional Digital Subtraction Angiography.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Nan DuDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Jing-Qin MaDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Jian-Jun LuoShanghai Institute of Medical Imaging, Shanghai 200041, China.
Qing-Xin LiuDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zi-Han ZhangDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Min-Jie YangDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Tian-Zhu YuDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Yun TaoDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Rong LiuDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Wen ZhangDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.ORCID 0000-0002-2301-147X
Zhi-Ping YanDepartment of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.ORCID 0000-0002-9352-3526
Fudan University · CNShanghai Institute of Hematology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study was to evaluate the safety and efficacy of transcatheter arterial embolization (TAE) in patients with renal hemorrhage after percutaneous nephrolithotomy (PCNL) and evaluate the risk factors that may result in severe bleeding requiring TAE.

methodsWe retrospectively reviewed 121 patients with post-PCNL renal hemorrhage. Thirty-two patients receiving endovascular embolization were compared with 89 patients only receiving conservative treatment. The demographic and clinical data were recorded and compared between the two groups. The values of estimated glomerular filtration rate (eGFR) and serum creatinine (SCr) were recorded preoperatively, postoperatively, and at last follow-up and analyzed to evaluate the safety and efficiency of TAE.

resultsThe successful hemostasis rate of conservative therapy was 73.6% (89/121) and that of TAE was 100% (32/32). SCr and eGFR were not significantly different before PCNL and after the last follow-up of TAE (SCr: 0.95 vs. 0.95 mg/dl,

conclusionTAE is a safe and effective procedure to treat renal hemorrhage that cannot be resisted by conservative treatment after PCNL. Diabetes mellitus was associated with high risks of severe bleeding needing TAE after PCNL.

Indexed as

CatheterizationEmbolization, TherapeuticNephrolithotomy, PercutaneousFemaleHemorrhageHumansLogistic ModelsMaleMiddle AgedMultivariate AnalysisRenal ArteryTreatment Outcome

Identifiers

PMID31143774
PMCPMC6501270
OpenAlexW2942338570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.